CliClinical Artificial Intelligence in Europenica
lA market and competitive landscape across decision support, population health analytics, and clinical intelligence platforms
Executive Summary
Europe's clinical AI market is not one race but several running in parallel, and no single company — European or American — currently leads all of them.
Ambient documentation is dominated by Nabla, a French startup carrying a valuation most European AI companies never reach.
The largest single population-health data contract in Europe belongs to Palantir, a US defense-adjacent firm now facing sustained political pressure to be removed.
A UK "AI doctor" once valued near $4 billion collapsed into bankruptcy.
And the clearest evidence of how hard this market is to enter is a $12 billion American clinical-AI leader that chose to withdraw from Europe entirely — priced out by the cost and delay of getting certified under the EU's medical-device rules and its new AI-safety law — rather than try to clear them. This report maps the segment by category and by player, rather than through any single company's lens, and draws out what the pattern across all of them actually says about how this market is likely to consolidate.
Become a member and get full report
IntellBigence in Europe